Insider · CIK 0001941388
Nathan E Weaks
Files at CIVB (CIVISTA BANCSHARES, INC.). First filing Jul 31, 2025, latest Aug 21, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CIVB: CIVISTA BANCSHARES, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | CIVBbuy CIVISTA BANCSHARES, INC. | $9,925 500 shares | +5% | +24% from low-20% from high | |
| 28Weak | CIVISTA BANCSHARES, INC. | $9,975 500 shares | +5% | +24% from low-20% from high | |
| 33Weak | CIVISTA BANCSHARES, INC. | $59k 3,000 shares | +48% | +22% from low-21% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | CIVB CIVISTA BANCSHARES, INC. | POpen-market purchase Commonindirect: IRA | +500 | $19.85 | $9,925 | 10,283 | Aug 21, 2025 |
| Aug 18, 2025 | CIVB CIVISTA BANCSHARES, INC. | POpen-market purchase Commonindirect: IRA | +500 | $19.95 | $9,975 | 9,783 | Aug 19, 2025 |
| Jul 30, 2025 | CIVB CIVISTA BANCSHARES, INC. | POpen-market purchase Commonindirect: IRA | +1,794 | $19.88 | $36k | 8,077 | Jul 31, 2025 |
| Jul 30, 2025 | CIVB CIVISTA BANCSHARES, INC. | POpen-market purchase Commonindirect: IRA | +206 | $19.90 | $4,099 | 8,283 | Jul 31, 2025 |
| Jul 31, 2025 | CIVB CIVISTA BANCSHARES, INC. | POpen-market purchase Commonindirect: IRA | +1,000 | $19.35 | $19k | 9,283 | Jul 31, 2025 |
| May 12, 2025 | CIVB CIVISTA BANCSHARES, INC. | AGrant or award Common | +1,027 | $0.00 | $0 | 3,339 | May 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.